A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
ACTIVE_NOT_RECRUITING
Status
Conditions
- Moderate to Severe Glabellar Lines
Interventions
- BIOLOGICAL: Rcombinant botulinum neurotoxin type A for injection (YY001)
Sponsor
Chongqing Claruvis Pharmaceutical Co., Ltd.